November 29, 2024 Holiday Shopping Sets New Records With $6.1B Spent Online
November 25, 2024 Bitcoin Nears $100K: Crypto Revolution Reshapes Wall Street
November 18, 2024 Biden’s Missile Strategy: Escalation Or Path To Peace?
November 10, 2024 Wall Street Soars: Trump’s Victory Ignites Market Surge
Apple: Why The Future Looks Far Less Secure
Amazon: Still A Buy Thanks To Bedrock And Trainium
Amazon: Not A Second-Tier AI Player Anymore, But I Need Better Numbers
The Market Is Wrong About Microsoft – Here’s Why
December 9, 2024 When to Switch Payroll Solutions and How to Make a Smooth Transition
November 24, 2024 Latest Finance Management Regulations in Australia
November 24, 2024 Finance Management Education Resources
November 18, 2024 Best Backtesting Software For Traders
November 18, 2024 Best Forex Trading Tools
Biohaven Pharmaceutical Holding (BHVN) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: December 11, 2024 (08:31)
Sector: HealthcareThe share price of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) now
Are you interested in Biohaven Pharmaceutical Holding Company Ltd. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Biohaven Pharmaceutical Holding stock price in 2025, 2026, 2027. How much will one Biohaven Pharmaceutical Holding share be worth in 2025 - 2027?
When should I take profit in Biohaven Pharmaceutical Holding stock? When should I record a loss on Biohaven Pharmaceutical Holding stock? What are analysts' forecasts for Biohaven Pharmaceutical Holding stock? What is the future of Biohaven Pharmaceutical Holding stock? We forecast Biohaven Pharmaceutical Holding stock performance using neural networks based on historical data on Biohaven Pharmaceutical Holding stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Biohaven Pharmaceutical Holding stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Biohaven Pharmaceutical Holding shares. This happens once a day.
Historical and forecast chart of Biohaven Pharmaceutical Holding stock
The chart below shows the historical price of Biohaven Pharmaceutical Holding stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Biohaven Pharmaceutical Holding stock price can be found in the table below.
Long-term forecasts by years.
Biohaven Pharmaceutical Holding Company Ltd., a clinical stage biopharmaceutical company, is developing advanced candidate products targeting neurological diseases and rare disorders in the United States. Its clinical stage products include Rimehepant, a product that has completed phase III trials for the acute treatment and prevention of migraines; Vasegepant, which has completed phase 2/3 trials for acute treatment and prevention of migraine; and Troriluzole, which has completed phase II / III randomization and is continuing with extended trials for ataxia. The company also offers Troril uzole, which is a phase II / III clinical stage for obsessive-compulsive disorder and Alzheimer’s disease; BHV-0223, product for amyotrophic lateral sclerosis; BHV-5000, a product that has completed phase I clinical trials for neuropsychiatric disorders; and Verdiperstat, a product that is in phase III clinical trials for multiple systemic atrophy. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine assessment of migraine sufferers. The company was founded in 2013 and is headquartered in New Haven, Connecticut.
Biohaven Pharmaceutical Holding daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec 13 | 41.91 | 41.44 | 42.29 | 2.06 |
| Dec 14 | 41.96 | 41.54 | 42.41 | 2.09 |
| Dec 15 | 42.29 | 41.77 | 43.05 | 3.07 |
| Dec 16 | 41.32 | 40.57 | 41.95 | 3.39 |
| Dec 17 | 41.56 | 41.11 | 42.09 | 2.37 |
| Dec 18 | 41.50 | 40.75 | 42.29 | 3.76 |
| Dec 19 | 41.90 | 40.96 | 42.70 | 4.27 |
| Dec 20 | 42.15 | 41.19 | 43.14 | 4.73 |
| Dec 21 | 42.23 | 41.54 | 42.57 | 2.47 |
| Dec 22 | 42.58 | 41.64 | 43.08 | 3.47 |
| Dec 23 | 42.98 | 42.64 | 43.52 | 2.06 |
| Dec 24 | 44.16 | 43.78 | 44.43 | 1.48 |
| Dec 25 | 43.73 | 42.95 | 44.07 | 2.60 |
| Dec 26 | 44.75 | 44.21 | 45.81 | 3.61 |
| Dec 27 | 44.12 | 43.64 | 44.70 | 2.43 |
| Dec 28 | 44.75 | 43.93 | 45.40 | 3.33 |
| Dec 29 | 45.65 | 44.69 | 46.67 | 4.41 |
| Dec 30 | 45.35 | 44.74 | 46.02 | 2.86 |
| Dec 31 | 45.07 | 44.23 | 46.03 | 4.07 |
| Jan 01 | 43.74 | 43.40 | 44.24 | 1.94 |
| Jan 02 | 43.87 | 42.82 | 44.41 | 3.72 |
| Jan 03 | 42.94 | 42.02 | 43.90 | 4.48 |
| Jan 04 | 43.84 | 43.55 | 44.69 | 2.63 |
| Jan 05 | 44.21 | 43.62 | 44.53 | 2.07 |
| Jan 06 | 44.06 | 43.00 | 45.12 | 4.92 |
| Jan 07 | 43.78 | 42.93 | 44.53 | 3.73 |
| Jan 08 | 43.08 | 42.75 | 43.77 | 2.39 |
| Jan 09 | 42.52 | 42.10 | 42.99 | 2.12 |
| Jan 10 | 42.91 | 42.61 | 43.91 | 3.05 |
| Jan 11 | 42.32 | 41.94 | 42.84 | 2.15 |
Biohaven Pharmaceutical Holding Daily Price Targets
Biohaven Pharmaceutical Holding Stock Forecast 12-13-2024.
Forecast target price for 12-13-2024: $41.91.
Negative dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 2.022%.
Pessimistic target level: 41.44
Optimistic target level: 42.29
Biohaven Pharmaceutical Holding Stock Forecast 12-14-2024.
Forecast target price for 12-14-2024: $41.96.
Positive dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 2.049%.
Pessimistic target level: 41.54
Optimistic target level: 42.41
Biohaven Pharmaceutical Holding Stock Forecast 12-15-2024.
Forecast target price for 12-15-2024: $42.29.
Positive dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 2.976%.
Pessimistic target level: 41.77
Optimistic target level: 43.05
Biohaven Pharmaceutical Holding Stock Forecast 12-16-2024.
Forecast target price for 12-16-2024: $41.32.
Negative dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 3.280%.
Pessimistic target level: 40.57
Optimistic target level: 41.95
Biohaven Pharmaceutical Holding Stock Forecast 12-17-2024.
Forecast target price for 12-17-2024: $41.56.
Positive dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 2.311%.
Pessimistic target level: 41.11
Optimistic target level: 42.09
Biohaven Pharmaceutical Holding Stock Forecast 12-18-2024.
Forecast target price for 12-18-2024: $41.50.
Negative dynamics for Biohaven Pharmaceutical Holding shares will prevail with possible volatility of 3.622%.
Pessimistic target level: 40.75
Optimistic target level: 42.29
BHVN (BHVN) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan. | 47.91 | 45.75 | 51.81 | 11.70 |
| Feb. | 46.75 | 45.52 | 47.88 | 4.94 |
| Mar. | 47.99 | 44.19 | 51.10 | 13.53 |
| Apr. | 43.03 | 40.85 | 44.49 | 8.19 |
| May. | 41.23 | 38.01 | 44.04 | 13.70 |
| Jun. | 40.50 | 37.56 | 43.93 | 14.50 |
| Jul. | 42.42 | 40.36 | 43.49 | 7.19 |
| Aug. | 40.55 | 38.68 | 41.93 | 7.77 |
| Sep. | 42.25 | 39.50 | 45.08 | 12.37 |
| Oct. | 40.29 | 37.28 | 43.04 | 13.39 |
| Nov. | 40.03 | 38.09 | 42.10 | 9.52 |
| Dec. | 41.61 | 38.41 | 43.63 | 11.96 |
Biohaven Pharmaceutical Holding forecast for this year
Biohaven Pharmaceutical Holding Stock Prediction for Jan 2025
An uptrend is forecast for this month with an optimal target price of $47.9123. Pessimistic: $45.75. Optimistic: $51.81
Biohaven Pharmaceutical Holding Stock Prediction for Feb 2025
An downtrend is forecast for this month with an optimal target price of $46.7529. Pessimistic: $45.52. Optimistic: $47.88
Biohaven Pharmaceutical Holding Stock Prediction for Mar 2025
An uptrend is forecast for this month with an optimal target price of $47.9871. Pessimistic: $44.19. Optimistic: $51.10
Biohaven Pharmaceutical Holding Stock Prediction for Apr 2025
An downtrend is forecast for this month with an optimal target price of $43.0253. Pessimistic: $40.85. Optimistic: $44.49
Biohaven Pharmaceutical Holding Stock Prediction for May 2025
An downtrend is forecast for this month with an optimal target price of $41.2268. Pessimistic: $38.01. Optimistic: $44.04
Biohaven Pharmaceutical Holding Stock Prediction for Jun 2025
An downtrend is forecast for this month with an optimal target price of $40.5012. Pessimistic: $37.56. Optimistic: $43.93
Biohaven Pharmaceutical Holding Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $42.4169. Pessimistic: $40.36. Optimistic: $43.49
Biohaven Pharmaceutical Holding Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $40.5506. Pessimistic: $38.68. Optimistic: $41.93
Biohaven Pharmaceutical Holding Stock Prediction for Sep 2025
An uptrend is forecast for this month with an optimal target price of $42.2456. Pessimistic: $39.50. Optimistic: $45.08
Biohaven Pharmaceutical Holding Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $40.2939. Pessimistic: $37.28. Optimistic: $43.04
Biohaven Pharmaceutical Holding Stock Prediction for Nov 2025
An downtrend is forecast for this month with an optimal target price of $40.0279. Pessimistic: $38.09. Optimistic: $42.10
Biohaven Pharmaceutical Holding Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $41.613. Pessimistic: $38.41. Optimistic: $43.63
Biohaven Pharmaceutical Holding (BHVN) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 44.59 | 41.60 | 46.80 | 11.11 |
| Feb | 45.42 | 43.87 | 47.32 | 7.29 |
| Mar | 49.02 | 47.19 | 51.93 | 9.14 |
| Apr | 50.21 | 46.84 | 51.37 | 8.82 |
| May | 54.68 | 53.24 | 58.83 | 9.51 |
| Jun | 57.87 | 54.94 | 59.71 | 8.00 |
| Jul | 57.23 | 52.57 | 60.63 | 13.29 |
| Aug | 54.33 | 52.30 | 55.95 | 6.52 |
| Sep | 51.88 | 47.77 | 54.97 | 13.08 |
| Oct | 53.37 | 50.67 | 57.24 | 11.49 |
| Nov | 53.13 | 49.92 | 56.35 | 11.41 |
| Dec | 53.66 | 50.71 | 55.78 | 9.10 |
Biohaven Pharmaceutical Holding (BHVN) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 54.66 | 52.08 | 59.29 | 12.17 |
| Feb | 56.83 | 52.89 | 58.58 | 9.71 |
| Mar | 54.39 | 51.88 | 58.70 | 11.62 |
| Apr | 53.49 | 49.49 | 57.85 | 14.44 |
| May | 53.32 | 51.97 | 56.01 | 7.22 |
| Jun | 50.15 | 47.17 | 53.24 | 11.40 |
| Jul | 50.81 | 49.30 | 52.38 | 5.87 |
| Aug | 49.92 | 46.02 | 52.99 | 13.16 |
| Sep | 52.17 | 48.95 | 56.36 | 13.14 |
| Oct | 55.61 | 51.02 | 58.97 | 13.48 |
| Nov | 56.28 | 52.14 | 59.26 | 12.02 |
| Dec | 56.72 | 53.35 | 61.02 | 12.58 |
Biohaven Pharmaceutical Holding information and performance
C/O BIOHAVEN PHARMACEUTICALS, INC., 215 CHURCH STREET, NEW HAVEN, CT, UNITED STATES
Market capitalization of the Biohaven Pharmaceutical Holding Company Ltd. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BHVN shares in the company outstanding by the market price of one share.
EBITDA of Biohaven Pharmaceutical Holding is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
